Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma

OBJECTIVE: Well‐differentiated (WDLPS) and dedifferentiated liposarcoma (DDLPS) account for the majority of liposarcomas. Although gemcitabine‐docetaxel is used as second‐line treatment in soft tissue sarcomas, its efficacy in WDLPS/DDLPS is not established. This study retrospectively analyzed the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Thirasastr, Prapassorn, Lin, Heather, Amini, Behrang, Wang, Wei‐Lien, Cloutier, Jeffrey M., Nassif, Elise F., Keung, Emily Z., Roland, Christina L., Feig, Barry, Araujo, Dejka, Benjamin, Robert S., Conley, Anthony P., Livingston, John A., Ludwig, Joseph, Patel, Shreyaskumar, Ratan, Ravin, Ravi, Vinod, Zarzour, Maria Alejandra, Zhou, Xiao, Somaiah, Neeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972024/
https://www.ncbi.nlm.nih.gov/pubmed/36151848
http://dx.doi.org/10.1002/cam4.5298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972024/
https://www.ncbi.nlm.nih.gov/pubmed/36151848
http://dx.doi.org/10.1002/cam4.5298

Ejemplares similares